Is it time to reconsider the locoregional approach in HER2+ breast cancer?
Philip Poortmans • 3 May 2022
Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Keep up to date with all the latest news with our monthly newsletter